Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

8.14
Delayed Data
As of 3:29pm ET
 +0.03 / +0.37%
Today’s Change
5.06
Today|||52-Week Range
9.71
+5.17%
Year-to-Date

Today’s Trading

Previous close8.11
Today’s open8.07
Day’s range8.04 - 8.24
Volume25,868
Average volume (3 months)98,650
Market cap$274.9M
Dividend yield--
Data as of 3:29pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)+16.15%
Earnings growth (this year)+21.79%
Earnings growth (next 5 years)--
Revenue growth (last year)+31.48%
P/E ratioNM
Price/Sales3.43
Price/Book4.60

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...-0.05-1.82%
OXFDOxford Immunotec Glo...+0.11+0.69%
QTNTQuotient Ltd-0.05-1.23%
TRIBTrinity Biotech PLC+0.05+0.95%
Data as of 3:43pm ET, 08/16/2017

Financials

Next reporting dateNovember 27, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$65.1M
Annual profit (last year)-$31.4M
Net profit margin-48.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Bonnie H. Anderson
President &
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts